Glutamate (Glu) is the most abundant excitatory neurotransmitter in the central nervous system (CNS) and is involved in the pathophysiology of Alzheimer’s disease (AD) in which there is an increased excitotoxicity. Biochemical composition of living tissues including the levels of Glu was analyzed by magnetic resonance spectroscopy (MRS). Previous reports point to decreased levels ofContinue reading “Decreased Brain Glutamate in Alzheimer’s Disease and excitotoxic effect of Glutamate in Parkinson’s disease”